Lauren Martz - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Lauren Martz's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Lauren Martz

Lauren Martz

Verified

Executive Director, Biopharma Intelligence, BioCentury

Philadelphia

Journalist Type

Seniority Positions

Industries

Medium Formats

Content

Total articles 849

  • Reduced animal testing could unlock host of benefits, but not overnight

    By Lauren Martz| BioCentury Verified ARTICLE | Product DevelopmentFDA outlines three-year road map to reduce animal safety studies for mAbs By Lauren Martz, Executive Director, Biopharma Intelligence FDA’s plan to move away from animal tox testing is not new — it’s been decades in the making — but the moment might be right for accelerating progress.

    By Lauren Martz · BioCentury

    Apr. 14, 2025

  • Cartesian's autoimmune CAR T looks durable, Arvinas’ LRRK2 data, and more: Clinical Report

    By Lauren Martz| BioCentury Verified ARTICLE | Product DevelopmentThe week’s gainers and decliners after data readouts By Lauren Martz, Executive Director, Biopharma Intelligence and Paul Bonanos, Director of Biopharma IntelligenceA CAR T cell therapy designed for repeat dosing in autoimmune disease patients has shown durable efficacy after 12 months of follow up. Yet, its maker, Cartesian Therapeutics, like most other companies with positive data this week, got caught up in the market downturn.

    By Lauren Martz · BioCentury

    Apr. 09, 2025

  • Reduced animal testing could unlock host of benefits, but not overnight

    By Lauren Martz| BioCentury Verified ARTICLE | Product DevelopmentFDA outlines three-year road map to reduce animal safety studies for mAbs By Lauren Martz, Executive Director, Biopharma Intelligence FDA’s plan to move away from animal tox testing is not new — it’s been decades in the making — but the moment might be right for accelerating progress.

    By Lauren Martz · BioCentury

    Apr. 14, 2025

As seen in

Company Info

BioCentury

BioCentury Inc. is a biotechnology-focused business intelligence and analytics company based in Redwood City, California. With over 30 years of experience, it specializes in providing strategic insights and data analysis tailored to the biopharma and biotech industries. The company reported a revenue of $16.2 million. BioCentury offers the BCIQ platform, which includes modules for tracking companies, products, and financial data. This platform helps clients identify trends, partnerships, and investment opportunities. Additionally, BioCentury provides analytical content that includes market trend analysis, visual data tools, and expert interviews. The company also facilitates networking through exclusive events and workshops, connecting C-suite executives and investors within the biopharma community.

'+1 650-595-5333

Founded: 1992